NYSE$RMD
ResMed Inc · Q4 2020 earnings
Q4 2020 earnings · · Investor relations
Briefing
ResMed's Q4 2020 earnings were announced, with revenue increasing by 9% and non-GAAP operating profit up by 24%.
ResMed Inc. reported a 9% increase in revenue to $770.3 million for the fourth quarter of fiscal year 2020. Non-GAAP diluted earnings per share were $1.33, a 40% increase compared to the prior year period. The company saw strong sales across its mask product portfolio and increased demand for ventilators due to COVID-19.
- Revenue increased by 9% to $770.3 million, or 10% on a constant currency basis.
- GAAP diluted earnings per share were $1.22, while non-GAAP diluted earnings per share reached $1.33.
- Net operating profit increased by 84%, with non-GAAP operating profit up by 24%.
- The company supported the COVID-19 pandemic response through increased manufacturing of ventilators and ventilation mask systems.
Headline financials
Revenue & EPS history
ResMed · Revenue · Quarterly
$770M
Revenue by segment
ResMed · $770M total across 3 segments · Q4 2020
- Total Devices$412M—53.4%
- Total Masks and other$267M—34.7%
- Residential Care Software$91.5M—11.9%
Forward guidance
ResMed is confident in its ability to navigate through the ongoing challenging clinical and economic environment to deliver for all stakeholders. Sleep labs and physician practices are reopening across many geographies, and the company is seeing accelerated adoption of digital health solutions which supports its long-term strategy.
Tailwinds
- Sleep labs and physician practices are reopening across many geographies.
- Accelerated adoption of digital health solutions.
- Strong foundation to accelerate growth over the longer term.
- Increased manufacturing of ventilators.
- Supporting customers with digital health solutions.
Headwinds
- Ongoing challenging clinical and economic environment.
- Uncertain environment.
- Declines in manufacturing and procurement efficiencies driven by higher air freight costs.
- Impact of legal settlement expenses in the prior year.
- COVID-19 pandemic.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q4 2020
+0.1%
Avg return
Earnings day
+0.7%
Avg return
5 days after
+1.2%
Avg return
30 days after
49%
33 / 67 earnings
Positive
+18.7%
Q3 2024
Best reaction
-19.3%
Q2 2019
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q3 2026 | -2.9% | -2.0% | -10.8% | |
| Q2 2026 | -1.5% | +2.1% | -0.5% | |
| Q1 2026 | -1.5% | -2.8% | +1.4% | |
| Q3 2025 | +10.1% | +10.9% | +13.2% | |
| Q2 2025 | -8.3% | -5.8% | -9.4% | |
| Q1 2025 | +7.9% | +2.9% | +2.7% | |
| Q4 2024 | +4.9% | +2.6% | +14.9% | |
| Q3 2024 | +18.7% | +16.4% | +16.0% | |
| Q2 2024 | +6.5% | +9.3% | +5.2% | |
| Q1 2024 | -4.2% | +0.5% | +9.5% | |
| Q4 2023 | -19.3% | -19.3% | -28.3% | |
| Q3 2023 | +7.6% | +5.4% | -3.8% | |
| Q2 2023 | -2.8% | -1.2% | -8.5% | |
| Q1 2023 | -6.5% | -5.6% | -1.7% | |
| Q4 2022 | -1.5% | -3.1% | -3.1% | |
| Q3 2022 | -6.9% | -8.5% | -3.0% | |
| Q2 2022 | -6.5% | +0.5% | +6.2% | |
| Q1 2022 | -1.9% | -2.1% | -6.3% | |
| Q4 2021 | +0.5% | +0.7% | +8.3% | |
| Q3 2021 | -10.6% | -8.6% | -2.0% | |
| Q2 2021 | -5.8% | -3.5% | -9.9% | |
| Q1 2021 | +6.2% | +12.1% | +16.0% | |
| Q4 2020 | -13.4% | -13.6% | -14.4% | |
| Q3 2020 | +1.8% | +2.0% | +2.9% | |
| Q2 2020 | -4.1% | +0.6% | -4.1% | |
| Q1 2020 | +13.8% | +15.7% | +14.6% | |
| Q4 2019 | +1.1% | +3.8% | +5.4% | |
| Q3 2019 | +7.9% | +7.6% | +9.3% | |
| Q2 2019 | -19.3% | -21.5% | -13.6% | |
| Q1 2019 | +6.2% | +7.3% | +5.7% | |
| Q4 2018 | -2.1% | +0.7% | +4.1% | |
| Q3 2018 | -2.1% | -1.4% | +6.9% | |
| Q2 2018 | +13.2% | +15.9% | +5.1% | |
| Q1 2018 | +7.7% | +7.4% | +8.6% | |
| Q4 2017 | -6.0% | -2.6% | +0.6% | |
| Q3 2017 | -5.2% | -2.7% | -2.3% | |
| Q2 2017 | +9.5% | +7.1% | +13.7% | |
| Q1 2017 | -5.0% | -5.3% | -8.7% | |
| Q4 2016 | +5.8% | +6.5% | +6.0% | |
| Q3 2016 | -7.4% | — | — | |
| Q2 2016 | +7.1% | — | — | |
| Q1 2016 | +0.1% | — | — | |
| Q4 2015 | +3.6% | — | — | |
| Q3 2015 | -10.3% | — | — | |
| Q2 2015 | +8.6% | — | — | |
| Q1 2015 | +9.5% | — | — | |
| Q4 2014 | -4.1% | — | — | |
| Q3 2014 | -0.4% | — | — | |
| Q2 2014 | -5.7% | — | — | |
| Q1 2014 | -13.2% | — | — | |
| Q4 2013 | +0.5% | — | — | |
| Q3 2013 | +0.9% | — | — | |
| Q2 2013 | +7.0% | — | — | |
| Q1 2013 | -4.7% | — | — | |
| Q4 2012 | +12.8% | — | — | |
| Q3 2012 | +7.6% | — | — | |
| Q2 2012 | +9.7% | — | — | |
| Q1 2012 | -12.0% | — | — | |
| Q4 2009 | -5.4% | — | — | |
| Q4 2011 | -5.4% | — | — | |
| Q3 2011 | -0.9% | — | — | |
| Q3 2010 | -0.9% | — | — | |
| Q2 2010 | +2.2% | — | — | |
| Q2 2011 | +2.2% | — | — | |
| Q1 2010 | +3.6% | — | — | |
| Q1 2011 | +3.6% | — | — | |
| Q4 2010 | +3.6% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro